Cargando…

Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma

OBJECTIVE: Multiple myeloma (MM) is currently incurable due to refractory disease relapse even under novel anti-myeloma treatment. In silico studies are effective for key decision making during clinicopathological battles against the chronic course of MM. The aim of this present in silico study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghasemi, Mehdi, Alpsoy, Semih, Türk, Seyhan, Malkan, Ümit Y., Atakan, Şükrü, Haznedaroğlu, İbrahim C., Güneş, Gürsel, Gündüz, Mehmet, Yılmaz, Burak, Etgül, Sezgin, Aydın, Seda, Aslan, Tuncay, Sayınalp, Nilgün, Aksu, Salih, Demiroğlu, Haluk, Özcebe, Osman İ., Büyükaşık, Yahya, Göker, Hakan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204182/ https://www.ncbi.nlm.nih.gov/pubmed/27095044 http://dx.doi.org/10.4274/tjh.2015.0145

Ejemplares similares

Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission
por: Aydın, Mürüvvet Seda, et al.
Publicado: (2017)

The Prognosis of Adult Burkitt’s Cell Leukemia in Real-Life Clinical Practice
por: Malkan, Ümit Yavuz, et al.
Publicado: (2016)

Comparison of bortezomibcyclophosphamide- dexamethasone versus bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients
por: Ciftciler, Rafiye, et al.
Publicado: (2020)

The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
por: OKAY, Müfide, et al.
Publicado: (2019)

Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation
por: Çiftçiler, Rafiye, et al.
Publicado: (2021)

Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems
por: Bektaş, Özlen, et al.
Publicado: (2016)

The Factors Affecting Early Death in Newly Diagnosed APL Patients
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

A single-center experience of haploidentical stem cell transplantation in hematological malignancies
por: MALKAN, Ümit Yavuz, et al.
Publicado: (2022)

CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation
por: ALADAĞ, Elifcan, et al.
Publicado: (2020)

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem cell transplantation
por: KARATAŞ, Ayşe, et al.
Publicado: (2022)

Indications and Outcomes of Splenectomy for Hematological Disorders
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
por: Çiftçiler, Rafiye, et al.
Publicado: (2019)

Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency
por: ALADAĞ, Elifcan, et al.
Publicado: (2019)

Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease
por: Gunes, Gursel, et al.
Publicado: (2015)

The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients
por: KARATAŞ, Ayşe, et al.
Publicado: (2021)

Immunosuppression-associated posterior reversible encephalopathy syndrome in an acute leukemia case
por: Malkan, Umit Y., et al.
Publicado: (2018)

Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study
por: Çınar, Olgu Erkin, et al.
Publicado: (2022)

The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
por: Işık, Ayşe, et al.
Publicado: (2013)

Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia
por: Serefhanoglu, Songul, et al.
Publicado: (2010)

Co-expression of t(15;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature
por: UZ, Burak, et al.
Publicado: (2013)

Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms
por: Eliaçık, Eylem, et al.
Publicado: (2015)

The effects of blood group types on the risk of COVID-19 infection and its clinical outcome
por: GÖKER, Hakan, et al.
Publicado: (2020)

The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia
por: Ghasemi, Mehdi, et al.
Publicado: (2019)

Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines
por: Turk, Seyhan, et al.
Publicado: (2017)

Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: ALADAĞ, Elifcan, et al.
Publicado: (2021)

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
por: Malkan, Umit Yavuz, et al.
Publicado: (2021)

Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells
por: Uz, Burak, et al.
Publicado: (2014)

Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center
por: Göker, Hakan, et al.
Publicado: (2023)

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation
por: Uz, B., et al.
Publicado: (2011)

Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case
por: Malkan, Umit Yavuz, et al.
Publicado: (2016)

Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

Nasal Natural Killer/T-cell Lymphoma with Skin, Eye, and Peroneal Nerve Involvement
por: Türker, Burcu, et al.
Publicado: (2012)

The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases
por: TÜRK, Can, et al.
Publicado: (2019)

Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
por: Karataş, Ayşe, et al.
Publicado: (2020)

Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide
por: Turk, Seyhan, et al.
Publicado: (2020)

Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma
por: Demiroğlu, Haluk, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eubrebobl37lhj4bi7u6t2o31s